New cancer drug NXP900 enters first human tests
NCT ID NCT05873686
First seen Mar 12, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This early-phase study tests a new drug called NXP900 in about 140 adults with advanced solid tumors (like lung, kidney, or mesothelioma) that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors or slow their growth. Participants will be closely monitored for side effects and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic
RECRUITINGPhoenix, Arizona, 85054, United States
Contact Phone: •••-•••-••••
-
Mayo Clinic
RECRUITINGJacksonville, Florida, 32224, United States
Contact Phone: •••-•••-••••
-
Mayo Clinic Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
NEXT Oncology Dallas
RECRUITINGIrving, Texas, 75039, United States
-
NEXT Oncology Houston
RECRUITINGHouston, Texas, 77054, United States
-
NEXT Oncology Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
Oregon Health and Science University
RECRUITINGPortland, Oregon, 97239, United States
Contact Phone: •••-•••-••••
-
Sarah Cannon Research Institute at HealthONE
RECRUITINGDenver, Colorado, 80218, United States
Contact Phone: •••-•••-••••
-
The Royal Marsden NHS Foundation and Trust
COMPLETEDLondon, SW3 6JJ, United Kingdom
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
-
Western General Hospital - NHS Lothian
COMPLETEDEdinburgh, EH4 2XU, United Kingdom
Conditions
Explore the condition pages connected to this study.